These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 36002196)

  • 1. [A Review on Pathological High-risk Factors and Postoperative Adjuvant Chemotherapy in Stage IA Lung Adenocarcinoma].
    Shen C; Fang W
    Zhongguo Fei Ai Za Zhi; 2022 Aug; 25(8):593-600. PubMed ID: 36002196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of surgery and adjuvant chemotherapy on the survival of stage I lung adenocarcinoma patients with tumor spread through air spaces.
    Lv Y; Li S; Liu Z; Ren Z; Zhao J; Tao G; Zheng Z; Han Y; Ye B
    Lung Cancer; 2023 Mar; 177():51-58. PubMed ID: 36736075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of postoperative adjuvant therapy on EGFR-mutated stage IA lung adenocarcinoma with micropapillary pathological subtypes.
    Cheng R; Hao Z; Qiu L; Zheng X; Huang S; Xian J; Huang H; Li J; Zhang Z; Ye K; Wu W; Zhang Y; Liu J
    World J Surg Oncol; 2024 Sep; 22(1):235. PubMed ID: 39232762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance and survival benefits of postoperative adjuvant chemotherapy in patients with stage IA lung adenocarcinoma with non-predominant micropapillary components.
    Li R; Qiu J; Li Z; Li H; Tang Z; Yu W; Tian H; Sun Z
    World J Surg Oncol; 2024 Jan; 22(1):32. PubMed ID: 38273367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of adjuvant chemotherapy for patients with pT2N0M0 non-small cell lung cancer receiving radical resection.
    Chen S; Yang S; Zhao Y; Zhang Y; Huang Q; Wu H; Hu H; Sun Y; Zhang Y; Xiang J; Ye T; Chen H
    Thorac Cancer; 2024 Jan; 15(3):258-265. PubMed ID: 38098268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of tumor spread through air spaces in patients with stage IA part-solid lung adenocarcinoma after sublobar resection.
    Chae M; Jeon JH; Chung JH; Lee SY; Hwang WJ; Jung W; Hwang Y; Cho S; Kim K; Jheon S
    Lung Cancer; 2021 Feb; 152():21-26. PubMed ID: 33338924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of epidermal growth factor receptor mutation status on adjuvant chemotherapy for patients with high-risk stage I lung adenocarcinoma.
    Tsutani Y; Ito M; Shimada Y; Ito H; Ikeda N; Nakayama H; Okada M
    J Thorac Cardiovasc Surg; 2022 Nov; 164(5):1306-1315.e4. PubMed ID: 35181001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival benefit of adjuvant chemotherapy after resection of Stage I lung adenocarcinoma containing micropapillary components.
    Li Y; Zhao J; Zhao Y; Li R; Dong X; Yao X; Xia Z; Xu Y; Li Y
    Cancer Med; 2024 Feb; 13(3):e7030. PubMed ID: 38400663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion of multiple high-risk histopathological criteria improves the prediction of adjuvant chemotherapy efficacy in lung adenocarcinoma.
    Sereno M; He Z; Smith CR; Baena J; Das M; Hastings RK; Rake G; Fennell DA; Nakas A; Moore DA; Le Quesne J
    Histopathology; 2021 May; 78(6):838-848. PubMed ID: 33155719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progress on the Study of Tumor Spread Through Air Spaces in the Clinicopathological Characteristics of Lung Adenocarcinoma and Its Influence on the Surgical Treatment and Prognosis of Lung Cancer].
    Qu G; Shi Y
    Zhongguo Fei Ai Za Zhi; 2019 Jun; 22(6):363-368. PubMed ID: 31196370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant difference in recurrence according to the proportion of high grade patterns in stage IA lung adenocarcinoma.
    Jeon HW; Kim YD; Sim SB; Moon MH
    Thorac Cancer; 2021 Jul; 12(13):1952-1958. PubMed ID: 34037324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy may improve prognosis after resection of stage I lung cancer with lymphovascular invasion.
    Wang S; Xu J; Wang R; Qian F; Yang W; Qiao R; Zhang B; Qian J; Yu K; Han B
    J Thorac Cardiovasc Surg; 2018 Nov; 156(5):2006-2015.e2. PubMed ID: 30104070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of blood and lymphatic vessel invasion in pathological stage IA lung adenocarcinoma in the 8th edition of the TNM classification.
    Samejima J; Yokose T; Ito H; Nakayama H; Nagashima T; Suzuki M; Hamanaka R; Yamada K; Masuda M
    Lung Cancer; 2019 Nov; 137():144-148. PubMed ID: 31593845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive Value of Recurrence of Solid and Micropapillary Subtypes in Lung Adenocarcinoma.
    Motono N; Mizoguchi T; Ishikawa M; Iwai S; Iijima Y; Uramoto H
    Oncology; 2024; 102(4):366-373. PubMed ID: 37899040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor Spread Through Air Spaces Is a Predictor of Occult Lymph Node Metastasis in Clinical Stage IA Lung Adenocarcinoma.
    Vaghjiani RG; Takahashi Y; Eguchi T; Lu S; Kameda K; Tano Z; Dozier J; Tan KS; Jones DR; Travis WD; Adusumilli PS
    J Thorac Oncol; 2020 May; 15(5):792-802. PubMed ID: 32007599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the presence of a micropapillary component predict worse prognosis in pathological stage IA lung adenocarcinoma?
    Wang Y; Song W; Wang X; Che G
    Pathol Res Pract; 2023 Feb; 242():154314. PubMed ID: 36706587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prognostic nomogram based on a new classification of combined micropapillary and solid components for stage IA invasive lung adenocarcinoma.
    Huang W; Zhang H; Zhang Z; Zhang B; Sun X; Huo Y; Feng Y; Tian P; Mo H; Wang C
    J Surg Oncol; 2022 Mar; 125(4):796-808. PubMed ID: 34862621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical Option for Stage IA Lung Adenocarcinoma With Spread Through Air Spaces.
    Bai W; Zhao K; Li S
    Ann Thorac Surg; 2022 Nov; 114(5):1988-1989. PubMed ID: 34929140
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathological vascular invasion and tumor differentiation predict cancer recurrence in stage IA non-small-cell lung cancer after complete surgical resection.
    Shimada Y; Saji H; Yoshida K; Kakihana M; Honda H; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    J Thorac Oncol; 2012 Aug; 7(8):1263-70. PubMed ID: 22673056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinicopathologic prediction model for postoperative recurrence in stage Ia non-small cell lung cancer.
    Zhang Y; Sun Y; Xiang J; Zhang Y; Hu H; Chen H
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1193-9. PubMed ID: 24667022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.